In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...